Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

NCT06321536 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Multi-Drug Resistant Organism Colonization

Interventions

DRUG: Allogeneic Microbiota in Glycerol (9%) (AMG)

Sponsor

Emory University

Collaborators

[object Object]